Profit Or Loss [Abstract]

Captor Therapeutics S.A. - Filing #6179999

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	9 158 PLN	—	—	3 986 PLN	—
Cost of sales	—	2 087 PLN	—	—	741,000 PLN	—
Gross profit	—	7 071 PLN	—	—	3 245 PLN	—
Other income	—	2 269 PLN	—	—	2 694 PLN	—
Administrative expenses	—	19 558 PLN	—	—	19 545 PLN	—
Other expense, by function	—	58,000 PLN	—	—	5 804 PLN	—
Profit (loss) from operating activities	—	38 364 PLN	—	—	31 709 PLN	—
Finance income	—	3 127 PLN	—	—	0 PLN	—
Finance costs	—	657,000 PLN	—	—	863,000 PLN	—
Profit (loss) before tax	—	35 894 PLN	—	—	32 572 PLN	—
Profit (loss) from continuing operations	—	35 894 PLN	—	—	32 572 PLN	—
Profit (loss)	35 894 PLN	35 894 PLN	35 894 PLN	32 572 PLN	32 572 PLN	32 572 PLN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	35 894 PLN	—	—	32 572 PLN	—
Earnings per share [text block]	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	861,000	—	—	789,000	—
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	824,000	—	—	748,000	—